The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedx Pharma Share News (REDX)

Share Price Information for Redx Pharma (REDX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.00
Bid: 8.00
Ask: 10.00
Change: -1.00 (-10.00%)
Spread: 2.00 (25.00%)
Open: 9.00
High: 9.00
Low: 9.00
Prev. Close: 10.00
REDX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK DIRECTOR DEALINGS SUMMARY: Braveheart Buys Stake In RMS From Brown

Wed, 01st Jul 2020 17:15

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Tuesday and Wednesday and not separately reported by Alliance News:

----------

Remote Monitored Systems PLC - London-based majority owner of GyroMetric Systems Ltd, which provides digital monitoring and safeguarding systems for rotating shafts on wind turbines - Braveheart Investment Group PLC buys 119.6 million shares from Executive Director Trevor Brown at 0.275 pence, worth GBP329,003, on Tuesday. Brown is chief executive officer of Braveheart, and payment for the RMS shares is in new Braveheart shares issued to Brown. Following the transaction, Braveheart owns 18.1% of RMS, and Brown has no interest. Brown now has a 24.8% stake in Braveheart. RMS owns 58% of GyroMetric and Braveheart owns 19.5%. Brown will remain on the RMS board to represent Braveheart.

----------

Savills PLC - London-based estate agent - James Sparrow, CEO of Savills UK & EMEA, sells 4,096 shares at GBP8.33, worth GBP34,100, on Friday last week. Still holds 58,475 shares.

----------

Babcock International Group PLC - London-based engineering services for defence - Chair Ruth Cairnie and associate buy 10,000 shares in total at GBP3.12 and GBP3.15, worth GBP31,333, on Wednesday.

----------

Qinetiq Group PLC - Farnborough, Hampshire-based security and defence contractor - Non-Executive Director Susan Searle buys 10,000 shares at GBP3.0244, worth GBP30,244, on Wednesday.

----------

Walker Greenbank PLC - Denham, Buckinghamshire-based interior furnishings - Non-Executive Director Christopher Rogers buys 52,500 shares at 37p, worth GBP19,425, on Tuesday. Now has 75,000 shares.

----------

Renew Holdings PLC - Leeds-based engineering services for infrastructure - Non-Executive Director Shatish Dasani and wife Dina buy 10,000 shares total at 444p, worth GBP44,400, on Tuesday. Dasani now interested in 15,000 shares.

----------

Staffline Group PLC - Nottingham-based recruitment and training firm - Three directors buy GBP70,857 in shares on Tuesday. Executive Chair Ian Lawson buys 131,577 shares at 39.00p, worth GBP51,315. Interim Chief Financial Officer Daniel Quint buys 25,320 shares at average 39.49p, worth GBP9,209. Non-Executive Director Richard Thomson buys 25,857 shares at average 39.96p, worth GBP10,333.

----------

Solid State PLC - Redditch, Worcestershire-based electronic components - Finance Director Peter James buys 2,520 shares at GBP5.95, worth GBP14,994. Now has 3,204 shares. Matthew Richards, managing director of subsidiary Steatite Ltd, buys 2,900 shares at GBP5.91, worth GBP17,126. Now has 10,375 shares. Both on Tuesday.

----------

ECSC Group PLC - Bradford-based cybersecurity firm - CEO Ian Mann buys 29,827 shares at average 67p, worth GBP19,984, on Wednesday. Now has 2.3 million shares, a 23% stake.

----------

Redx Pharma PLC - Macclesfield-based cancer and fibrosis drugs - Non-Executive Chair Iain Ross buys 215,870 shares at average 18.94p, worth GBP40,886, on Tuesday. Non-Executive Director Peter Presland buys 118,849 shares at 25p, worth GBP29,712, also on Tuesday. Both purchases are their only holdings.

----------

Trackwise Designs PLC - Tewkesbury, Gloucestershire-based printed circuit technology - Non-Executive Director Charles Cattaneo buys 10,000 shares at 86p, worth GBP8,600, on Tuesday. The shares are his only holding.

----------

UIL Ltd - closed-end Bermuda-incorporated investment company - Non-Executive Director Stuart Bridges buys 6,080 shares at 180p, worth GBP10,944, on Wednesday.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
19 Apr 2024 16:02

IN BRIEF: Redx Pharma shareholders approve AIM delisting plans

Redx Pharma PLC - clinical-stage biotechnology company - Shareholders pass resolution by 99.75% margin at general meeting to approve cancelling shares on AIM in London. This is now expected to take place on May 1, with last day of trading on April 30. Says it remains the company's intention to provide a matched bargain facility to assist shareholders wishing to trade in shares following the AIM delisting. Says it will make further details available in "due course" on its website.

Read more
12 Apr 2024 15:35

Director dealings: Redx Pharma CEO ups stake

(Sharecast News) - Redx Pharma revealed on Friday that chief executive Lisa Anson had acquired 399,000 ordinary shares in the AIM-listed clinical-stage biopharmaceutical firm.

Read more
2 Apr 2024 16:57

LONDON MARKET CLOSE: Europe down after Easter holiday weekend

(Alliance News) - The FTSE 100 took a hit on Tuesday, after a boost from London's miners and oil firms were not enough to lift the index.

Read more
2 Apr 2024 12:15

Redx Pharma plummets on plans to delist from AIM

(Alliance News) - Redx Pharma PLC shares fell on Tuesday, after it said it intends to cancel its shares from trading on AIM in London.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:50

AIM WINNERS & LOSERS: 88 Energy finds oil at Hickory-1; Redx to delist

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
14 Feb 2024 09:34

IN BRIEF: Redx Pharma clarifies not currently pursuing US listing

Redx Pharma PLC - Macclesfield, England-based clinical-stage biotechnology company - Responds to a Times article published on Tuesday saying RedX is looking to list its shares in New York. Redx says it "wishes to clarify that it is not currently in any process relating to a listing in the US, nor any other jurisdiction".

Read more
7 Feb 2024 11:08

Redx Pharma shares skyrocket on deal to sell inhibitor program

(Alliance News) - Redx Pharma PLC on Wednesday said it has struck a deal to sell Kirsten rat sarcoma virus inhibitor program to Dublin-based Jazz Pharmaceuticals PLC.

Read more
7 Feb 2024 09:29

AIM WINNERS & LOSERS: Verditek falls on cash shell plans

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
15 Dec 2023 21:09

EARNINGS AND TRADING: Redx full year revenue tumbles; loss widens

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
18 Oct 2023 12:30

Redx Pharma looks to progress portfolio after raising GBP14.1 million

(Alliance News) - Redx Pharma PLC on Wednesday said that it has conditionally raised around GBP14.1 million by way of a subscription for 54.1 million shares at 26 pence each.

Read more
21 Aug 2023 10:29

AIM WINNERS & LOSERS: Fulcrum Utility to leave AIM as loss widens

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
21 Aug 2023 09:33

Redx Pharma says RXC007 receives orphan drug designation from US FDA

(Alliance News) - Redx Pharma PLC on Monday said its RXC007 drug has received orphan drug designation from the US Food & Drug Administration for the treatment of idiopathic pulmonary fibrosis, a condition causing breathing difficulty due to lung scarring.

Read more
21 Aug 2023 07:43

LONDON BRIEFING: Crest Nicholson lowers annual profit forecast

(Alliance News) - Stocks in London are called flat on Monday, with little in the way of economic data or company updates to reignite risk appetite.

Read more
10 Jul 2023 11:22

Redx Pharma extends term of outstanding notes with two lenders to 2024

(Alliance News) - Redx Pharma PLC on Monday said it extended the term of its outstanding convertible loan notes issued to two lenders RM Special Holdings 3 LLC, otherwise known as Redmile, and Sofinnova Crossover I SLP by a year.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.